Please Wait.....
Report
Ovarian Cancer Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Report I 2023-10-15 I 142 Pages I IMARC Group
Market Overview:
The global ovarian cancer market size reached US$ 1.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2028, exhibiting a growth rate (CAGR) of 11.56% during 2023-2028.
Ovarian cancer refers to a malignant tumor wherein abnormal cells in the ovary begin to multiply and grow uncontrollably from the outer tissue lining or fallopian tubes due to mutagenic changes in the deoxyribonucleic acid (DNA). At present, it can be treated with the support of various diagnoses and drugs, including antirheumatics, antineoplastics, and PARP, mitotic, and VEGF/VEGFR inhibitors. Apart from this, ovarian cancer treatment involves surgery, chemotherapy, hormone, radiation, and targeted therapies that help kill cancer cells to provide relief from signs and systems. These therapeutics are executed by medical practitioners after determining multiple factors, such as the spread of the tumor, individuals' general health, and the size and type of ovarian cancer.
Ovarian Cancer Market Trends:
The increasing prevalence of epithelial, stromal, and germ cell ovarian cancer, especially amongst the female geriatric population, due to the genetic mutation of breast cancer gene 1 (BRCA1) or BRCA2, is primarily driving the market growth. In line with this, the rising need for effective therapeutic drugs, such as bevacizumab (Avastin) and pazopanib (Votrient), is acting as another growth-inducing factor. Additionally, the widespread adoption of combination therapies in the healthcare sector to prevent drug resistance and increase treatment efficacy is supporting the market growth. Moreover, the ongoing patent expiration of branded medications has prompted governments and pharmaceutical companies to launch novel recombinant drugs, which, in turn, is propelling market growth. Furthermore, extensive initiatives undertaken by non-governmental organizations (NGOs) to sensitize consumers regarding the symptoms, treatments, and benefits of early ovarian cancer diagnosis are impelling the market growth. Apart from this, strategic collaborations amongst key players and continuous research and development (R&D) activities to produce efficient therapeutic interventions are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global ovarian cancer market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, treatment type and end user.
Breakup by Type:
Epithelial Ovarian Cancer
Germ Cell Ovarian Cancer
Stromal Cell Ovarian Cancer
Breakup by Treatment Type:
Immunotherapy
Chemotherapy
Targeted Therapy
Surgery
Others
Breakup by End User:
Hospitals
Homecare
Speciality Centre
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amneal Pharmaceuticals Inc., AstraZeneca plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, GSK plc, Hikma Pharmaceuticals PLC, Lupin Limited, Pfizer Inc. and Teva Pharmaceutical Industries Ltd.
Key Questions Answered in This Report:
How has the global ovarian cancer market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global ovarian cancer market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the treatment type?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global ovarian cancer market and who are the key players?
What is the degree of competition in the industry?
1Preface
2Scope and Methodology
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3Executive Summary
4Introduction
4.1Overview
4.2Key Industry Trends
5Global Ovarian Cancer Market
5.1Market Overview
5.2Market Performance
5.3Impact of COVID-19
5.4Market Forecast
6Market Breakup by Type
6.1Epithelial Ovarian Cancer
6.1.1 Market Trends
6.1.2 Market Forecast
6.2Germ Cell Ovarian Cancer
6.2.1 Market Trends
6.2.2 Market Forecast
6.3Stromal Cell Ovarian Cancer
6.3.1 Market Trends
6.3.2 Market Forecast
7Market Breakup by Treatment Type
7.1Immunotherapy
7.1.1 Market Trends
7.1.2 Market Forecast
7.2Chemotherapy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3Targeted Therapy
7.3.1 Market Trends
7.3.2 Market Forecast
7.4Surgery
7.4.1 Market Trends
7.4.2 Market Forecast
7.5Others
7.5.1 Market Trends
7.5.2 Market Forecast
8Market Breakup by End User
8.1Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2Homecare
8.2.1 Market Trends
8.2.2 Market Forecast
8.3Speciality Centre
8.3.1 Market Trends
8.3.2 Market Forecast
8.4Others
8.4.1 Market Trends
8.4.2 Market Forecast
9Market Breakup by Region
9.1North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10SWOT Analysis
10.1Overview
10.2Strengths
10.3Weaknesses
10.4Opportunities
10.5Threats
11Value Chain Analysis
12Porters Five Forces Analysis
12.1Overview
12.2Bargaining Power of Buyers
12.3Bargaining Power of Suppliers
12.4Degree of Competition
12.5Threat of New Entrants
12.6Threat of Substitutes
13Price Analysis
14Competitive Landscape
14.1Market Structure
14.2Key Players
14.3Profiles of Key Players
14.3.1AbbVie Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2Amneal Pharmaceuticals Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3AstraZeneca plc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4Eli Lilly and Company
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5F. Hoffmann-La Roche AG
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6GSK plc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7Hikma Pharmaceuticals PLC
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8Lupin Limited
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9Pfizer Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10Teva Pharmaceutical Industries Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
Figure 1: Global: Ovarian Cancer Market: Major Drivers and Challenges
Figure 2: Global: Ovarian Cancer Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Ovarian Cancer Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Ovarian Cancer Market: Breakup by Type (in %), 2022
Figure 5: Global: Ovarian Cancer Market: Breakup by Treatment Type (in %), 2022
Figure 6: Global: Ovarian Cancer Market: Breakup by End User (in %), 2022
Figure 7: Global: Ovarian Cancer Market: Breakup by Region (in %), 2022
Figure 8: Global: Ovarian Cancer (Epithelial Ovarian Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Ovarian Cancer (Epithelial Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Ovarian Cancer (Germ Cell Ovarian Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Ovarian Cancer (Germ Cell Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Ovarian Cancer (Stromal Cell Ovarian Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Ovarian Cancer (Stromal Cell Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Ovarian Cancer (Immunotherapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Ovarian Cancer (Immunotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Ovarian Cancer (Chemotherapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Ovarian Cancer (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Ovarian Cancer (Targeted Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Ovarian Cancer (Targeted Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Ovarian Cancer (Surgery) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Ovarian Cancer (Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Ovarian Cancer (Other Treatment Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Ovarian Cancer (Other Treatment Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Ovarian Cancer (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Ovarian Cancer (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Ovarian Cancer (Homecare) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Ovarian Cancer (Homecare) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Ovarian Cancer (Speciality Centre) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Ovarian Cancer (Speciality Centre) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Ovarian Cancer (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Ovarian Cancer (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: North America: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: North America: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: United States: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: United States: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Canada: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Canada: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Asia-Pacific: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Asia-Pacific: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: China: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: China: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Japan: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Japan: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: India: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: India: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: South Korea: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: South Korea: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Australia: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Australia: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Indonesia: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Indonesia: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Others: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Others: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Europe: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Europe: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Germany: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Germany: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: France: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: France: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: United Kingdom: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: United Kingdom: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Italy: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Italy: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Spain: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Spain: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Russia: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Russia: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Others: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Others: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Latin America: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Latin America: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Brazil: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Brazil: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Mexico: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Mexico: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Middle East and Africa: Ovarian Cancer Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Middle East and Africa: Ovarian Cancer Market: Breakup by Country (in %), 2022
Figure 80: Middle East and Africa: Ovarian Cancer Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Global: Ovarian Cancer Industry: SWOT Analysis
Figure 82: Global: Ovarian Cancer Industry: Value Chain Analysis
Figure 83: Global: Ovarian Cancer Industry: Porter's Five Forces Analysis
Table 1: Global: Ovarian Cancer Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Ovarian Cancer Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Ovarian Cancer Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
Table 4: Global: Ovarian Cancer Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Ovarian Cancer Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Ovarian Cancer Market: Competitive Structure
Table 7: Global: Ovarian Cancer Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security